Literature DB >> 18311330

Bioavailability of heme iron in biscuit filling using piglets as an animal model for humans.

Adrián Guillermo Quintero-Gutiérrez1, Guillermina González-Rosendo, Jonathan Sánchez-Muñoz, Javier Polo-Pozo, José Juan Rodríguez-Jerez.   

Abstract

The objective of this work was to evaluate the bioavailability of heme iron added to biscuit filling. It comprised two stages: first, the development of the heme iron enriched biscuit filling; second, the evaluation of the bioavailability of the mineral in fattening piglets. Two groups were selected randomly and fed: a) Low iron feed and biscuits with heme iron supplemented filling; b) Normal feed (with ferrous sulphate). Weight and blood parameters were measured every fifteen days. Averages were compared after duplicate analyses. The filling had a creamy appearance, chocolate taste and smell, appropriate spreadability, heme iron content of 2.6 mg per gram and a shelf-life of a month. The heme iron supplemented pigs registered a greater (P<0.05) weight gain (27.8% more than the control group). Mortality in the heme iron group was 10%, compared to 50% in the control group. The amount of iron measured in the different compartment was greater in the heme group (3315 mg) than in the control group (2792 mg). However, the amount of iron consumed in the latter was greater. We show that an acceptable product with high heme iron content can be formulated, suitable for use as biscuit filling. The heme iron supplement produced better weight increase and lesser mortality in fattening pigs. The bioavailability of heme iron was 23% greater (P<0.05) compared to ferrous sulphate.

Entities:  

Keywords:  Heme iron; bioavailability; iron deficiency.; piglets; pigs

Mesh:

Substances:

Year:  2008        PMID: 18311330      PMCID: PMC2253952          DOI: 10.7150/ijbs.4.58

Source DB:  PubMed          Journal:  Int J Biol Sci        ISSN: 1449-2288            Impact factor:   6.580


INTRODUCTION

Although pervasively widespread in the world, iron is the nutrient with a most pronounced deficiency in humans 1, 2 Many remedial actions have been undertaken; nevertheless, the problem persists for a number of reasons: unspecific diet supplements, poor dietary food combinations and low bioavailability in the iron-bearing products consumed 3-5 Dietary iron occurs in two forms: 1) non-heme iron; derived mainly from vegetable products, and 2) heme iron; only found in products of animal origin 5, 6. Heme iron is more easily absorbed in the diet than inorganic iron; because the absorption process is different for each 7. There are experiences on the use of bovine and pig blood to exploit their high nutritional value and coincidentally eliminate a highly polluting effluent 8. These experiences show that a base product can be obtained with a high heme iron concentration and good bioavailability for direct consumption or food supplements 5, 9-11. Satisfactory results have been obtained with the addition of heme derivatives to some foods. For example, in 1993 Walter et al 12, achieved this with biscuits; Pallares et al 13 added bovine blood to a cereal with milk; Aznar and González 14, developed a protein-mineral food supplement (TROFIN), using dried whole blood with hydrolyzed proteins as a base. Many techniques are available for studying iron bioavailability, which can be classified as: in vitro studies and live studies depending on the model used the latter in either animals or humans 6. The in vitro studies are cheaper and permit a greater control over the experimental variables. The main limitation of these methods is that they cannot simulate physiological states or some physical and chemical properties and adaptive responses that influence the bioavailability of iron 15. Although recent methods have been developed attempt to correct these limitations and approach the absorption conditions in the small intestine 16. Absorption studies in humans continue to be the gold standard in estimating the bioavailability of iron; nevertheless, animals tests are often more practical for the prediction of nutrient bioavailability 6,17. The pig is considered a model that shares more human structure and function similarities than other animals. More variables can be measured, such as those related to the diet or growth rate. For these reasons, was chosen as the model for this study 18. The objective of this work was to evaluate the bioavailability of a heme iron concentrate product incorporated into a chocolate flavor biscuit filling.

MATERIAL AND METHODS

All analyses were performed by two replicates.

Development of biscuit filling

A previous study (data not shown) used a factor-by-factor procedure 19, to evaluate several ingredients and formulas (hydrocolloids among them); from this the definitive one was selected, consisting of 9 ingredients (table 1). By means of the researchers' direct observation and using an arbitrary scale (from 0 to 5), the spreadability, flow, colour, smell, flavor, adhesion, gumminess, firmness, cutting effort and radiance characteristics were measured.
Table 1

Formula of Heme iron enrichment filling

IngredientsInclusion %
Glucose15.9
Sugar39.7
Heme iron17.9
Simplesse-1005.0
Skimmed cocoa5.0
Cocoa flavor4.5
Titanium Dioxide1.5
Orange E-11010.5
Water10.0
Total100

1 Colorant to 20%.

Microbiological analyses

Microbiological checks were applied during the process and to the end product, making measurements of total counts, enterobacteria, moulds and yeasts, Salmonella spp. and Escherichia coli.

Working ingredient

The heme iron used for the fortification is a dark colour dust, obtained from animal blood from healthy pigs that have passed veterinary inspections satisfactorily in registered slaughter houses and hygienically collected after the addition of an appropriate anticoagulant. After the separation of the corpuscular fraction by centrifuging, a pressure pump is used to liberate the hemoglobin contained in the erythrocytes. The hemoglobin is later enzymatically hydrolyzed by a proteolytic enzyme (Alcalase®; Novo-Nordisk. Denmark) working within its specific conditions (pH 8,5 and 50ºC). Afterwards, globin peptones were separated from the heme group enriched concentrate by ultrafiltration. Protein, fat, humidity and ash were analyzed following the methodology proposed in the AOAC 20; iron and zinc were measured by Flame Atomic Absorption Photospectrometer in a PERKIN-ELMER Photospectrometer, 2100 model 21.

Bioavailability evaluation

The sample size calculation and the study itself was made with 20 common pigs (Sus scrofa domesticus), Belgian Pietrain; females, 4 weeks old, with an average weight of 7 Kg, that only received 100 mg of dextrane iron administration at birth with the intention of producing a slight iron deficiency at weaning. By means of random selection two groups of 10 piglets each were formed: Study group. This group was fed a low iron diet (452.7 mg/Kg) and sandwich biscuits with a chocolate flavor filling with added heme iron. Control group. This group was fed normal food, which contained ferrous sulphate (537.1 mg/Kg). The iron supplement was given during 20 weeks, making daily inspections, taking their weight and blood samples every fortnight, applying antiparasitic treatment as required and a veterinary check-up monthly. The blood samples were extracted from the superior cave vein after the pigs were tranquilized with Azaperone (Stresnil®). 7 ml of blood was extracted, of which 3 ml was put in a tube with EDTA to make the red series analyses; the rest of the blood (4 ml) was emptied into a tube with separating serum gel to make the biochemical analyses. The samples were transported from the farm to the laboratory refrigerated and they were immediately processed. The hematological measurements were made with an Advia (TM) 120 (Bayer Diagnostics Europe SL, 22, and the biochemical measurements with an COBAS MIRA 89 (ROCHE) Chemical Analyzing System, using the Ferrozine iron A11A00091 ABX commercial kit. The measurement of iron in the liver was made by atomic absorption spectrophotometer with PERKIN-ELMER equipment, model 2100, using a sample taken immediately after slaughtering and deep frozen to -20º C until the analysis 15 days later. This study was approved by the Autonomous University of Barcelona ethics commission. The end-point criteria for the experiment was either the existence of incapacitating or incurable disease or the completion of study (20 weeks); in both cases, slaughtering was done by administering sodium pentobarbital on the same pig farm 23,24.

Statistical analysis

The statistical analysis was done with the SPSS 13.0 software. First, descriptive analysis was performed, using duplicate determination of initial and final values, and comparing independent averages of the results of both groups.

RESULTS AND DISCUSSION

Table 2 shows the composition of the filling formulated; it may be observed that heme contribution of iron is 2,6 mg for each gram of filling, so a single biscuit containing 5 grams of product will contribute up to 13 mg of iron, covering 100% of the recommended iron intake for humans 25. The 14.1% protein content, being of hemoglobin and milk serum, is of high biological quality 26. The product additionally contains small amounts of other nutrients of possible nutritional value. The filling obtained was directly observed to have a creamy appearance, chocolate smell and flavor and appropriate spreadability.
Table 2

Chemical composition of enriched filling with Heme iron (100 g)

CompositionQuantity
Proteins, g14.1
Fat, g10.9
Carbohydrates, g65.2
Ash, g5.3
Humidity, %4.5
Iron, mg260.0
Zinc, mg0.8
The bioavailability evaluation began with 20 piglets, randomly separated into two groups. The expected values column 27 in table 3 gives some hematological reference parameters for piglets of similar ages and weights and, despite a relatively high variation coefficient, can be used as a guide to verify that the results obtained for most of the parameters studied were within the norm. We observed a high weight variation (variation coefficient 0.23), indicating a quite heterogeneous study group.
Table 3

Weight and hematological characteristics of piglets *, according to group and normality

ParameterStudy groups at the beginning **Normal reference values (26)
HemeControl
Weight, kg6.9 ± 1.76.9 ± 1.7-
Erythrocytes, 106/μl6.5 (1.0)6.00 (0.5)5-7
Hemoglobin, g/dl11.5 (1.5)11.7 (1.2)9-13
Hematocrite, %34.1 (7.4)32.5 (3.6)36-43
VCM, fl52.6 (6.7)54.3 (1.4)52-62
CMH, pgl18.0 (3.2)19.5 (1.9)17-24
CCMH, g/dl34.3 (4.9)36.0 (2.1)29-34
Seric iron, μ/dl212.7 (110.7)238.3 (84.4)172±60
Leucocytes, 103/μl21.5 (6.8)21.5 (3.1)11-22
Platelets, 103/μl448.2 (230.2)408.1 (118.1)200-500
Lymphocytes, %47.7 (12.0)60.2 (6.0)35-75
Monocytes, %3.9 (2.3)2.7 (1.3)0-10
Neutrophils, %42.1 (18.6)35.4 (7.2)20-70
Eosinophils, %1.9 (0.8)3.1 (0.5)0-10

* Expressed as average and standard deviation

** No statistical differences were detected (p>0.05)

- Not applied

Given the heterogeneousness of the group, care was exercised to ensure randomness in the separation into groups. Table 3 shows the characteristics of each. Some differences can be noted; nevertheless in all cases these were not statistically significant, therefore we can assume that the groups were not different and that the splitting process was satisfactory. Of the total number of pigs when the study began, 6 died during the trial, 5 from control group (50%) and 1 from heme group (10%). There was a risk that the pigs that died shared a common differentiating characteristic compared to the survivors, thereby slanting the results. However, comparing the values of variables of both groups, we observed that although there were slight differences in some variables they had no statistical significance, leading us to consider that there was no factor which influenced mortality differentially in the study groups, since both were subjected to the same treatment and therefore the same stress, probably the cause of the high mortality 28-30. Figure 1 shows the behavior of both study groups' weights; there was a slight not statistically significant difference between them from week 8 until week 13 (p>0,05); from which point the heme supplement group increasingly took off until the end of the study in week 20. Both groups started with an average weight of 6.9 (1.6) Kg; but the increase was much greater in the heme group, their final weight being 56.7 Kg, an increase of 49.8 Kg. In contrast, the control group, whose final weight average reached 43.9 Kg, an increase of 37 Kg, giving a statistically significant (p<0.05) difference of 12.8 Kg between the groups, and agreeing with the results obtained by Perestrelo and Perestrelo 31, who used amino-quelated iron in their supplement and concluded that it reduces mortality and improved growth.
Figure 1

Average of body weight of 20 piglets from 4 to 20 weeks of age.

On average, the heme group pigs consumed 10.5 Kg of sandwich biscuits (498 pieces), a total of 46,737 Kcal, which, when converted to animal weight at the rate of 9,200 Kcal per Kg 32, gives a total of 5.1 Kg of weight attributable to biscuit consumption. Therefore, the actual difference exclusively due to the heme iron source were 7.7 Kg (17.2%) in favor of the heme iron supplement group. Table 4 shows the iron measured in tissues and subsequently calculated for each tissue, as well as the sum of each and the percentage relative to the total iron consumed by the pigs throughout the study, according to the supplement group they belonged to. We can observe significant differences between the groups with respect to iron in the blood, but not in the other body parts, although the heme group showed values higher than the ferrous sulphate supplement group as regards both the liver and hemoglobin. The difference in absorption percentage between the groups was significant (P<0.05); the absorption of heme iron was shown to be 23% superior to ferrous sulphate.
Table 4

Iron quantity in different compartments (average and standard deviation) and percentage of iron absorption in relation to iron consumed

GroupsIron quantity mgAbsorption percentage *
Hemoglobin** FunctionalLiver** ReservesBlood* CirculatingTotal**Ingested
Heme iron3,032 (636)277 (131)6,2 (1.6)3,315 (689)63,9805.2 (1.0) 4.0 (1.0)
Control2,498 (723)287 (45)6.7 (1.7)2,792 (754)69,810

* Statistically significant differences p< 0.05.

** Statistically not significant differences. p>0.05.

In conclusion, the adverse characteristics of heme iron (dark colour, blood smell and flavor) can be transformed and exploited by its incorporation into a suitable base, which in this case was a chocolate flavored biscuit filling. Mortality was less in the heme iron supplement group of pigs; the weight also was greater in this group and there was a clear difference in favor of the heme iron group in the total measured iron averages; although the heme group pigs consumed less iron; therefore, we can conclude that the measured bioavailability of heme iron was greater than that of ferrous sulphate.
  14 in total

1.  Methodological issues in assessing bioavailability of nutrients and other bioactive substances in dietary supplements: summary of workshop discussion.

Authors:  R J Wood; T Tamura
Journal:  J Nutr       Date:  2001-04       Impact factor: 4.798

Review 2.  Adaptation in iron metabolism.

Authors:  J D Cook
Journal:  Am J Clin Nutr       Date:  1990-02       Impact factor: 7.045

3.  Recommendations for euthanasia of experimental animals: Part 1. DGXI of the European Commission.

Authors:  B Close; K Banister; V Baumans; E M Bernoth; N Bromage; J Bunyan; W Erhardt; P Flecknell; N Gregory; H Hackbarth; D Morton; C Warwick
Journal:  Lab Anim       Date:  1996-10       Impact factor: 2.471

4.  Recommendations for euthanasia of experimental animals: Part 2. DGXT of the European Commission.

Authors:  B Close; K Banister; V Baumans; E M Bernoth; N Bromage; J Bunyan; W Erhardt; P Flecknell; N Gregory; H Hackbarth; D Morton; C Warwick
Journal:  Lab Anim       Date:  1997-01       Impact factor: 2.471

5.  Supplementation of a cereal-milk formula with haem iron palliates the adverse effects of iron deficiency on calcium and magnesium metabolism in rats.

Authors:  I Pallarés; M S Campos; I López-Aliaga; M Barrionuevo; A E Gómez-Ayala; M J Alférez; S Hartiti; F Lisbona
Journal:  Ann Nutr Metab       Date:  1996       Impact factor: 3.374

6.  Iron absorption from concentrated hemoglobin hydrolysate by rat.

Authors:  Nikta Vaghefi; Fuzia Nedjaoum; Didier Guillochon; François Bureau; Pierre Arhan; Dominique Bouglé
Journal:  J Nutr Biochem       Date:  2005-06       Impact factor: 6.048

7.  Electrolytic iron or ferrous sulfate increase body iron in women with moderate to low iron stores.

Authors:  James H Swain; LuAnn K Johnson; Janet R Hunt
Journal:  J Nutr       Date:  2007-03       Impact factor: 4.798

8.  Effectiveness of iron-fortified infant cereal in prevention of iron deficiency anemia.

Authors:  T Walter; P R Dallman; F Pizarro; L Velozo; G Peña; S J Bartholmey; E Hertrampf; M Olivares; A Letelier; M Arredondo
Journal:  Pediatrics       Date:  1993-05       Impact factor: 7.124

Review 9.  Iron supplementation.

Authors:  K Schümann; B Elsenhans; A Mäurer
Journal:  J Trace Elem Med Biol       Date:  1998-11       Impact factor: 3.849

Review 10.  Pathways of iron absorption.

Authors:  Marcel E Conrad; Jay N Umbreit
Journal:  Blood Cells Mol Dis       Date:  2002 Nov-Dec       Impact factor: 3.039

View more
  9 in total

1.  Benefits and risks of iron supplementation in anemic neonatal pigs.

Authors:  Paweł Lipinski; Rafał R Starzyński; François Canonne-Hergaux; Barbara Tudek; Ryszard Oliński; Paweł Kowalczyk; Tomasz Dziaman; Olivier Thibaudeau; Mikołaj A Gralak; Ewa Smuda; Jarosław Woliński; Agnieszka Usińska; Romuald Zabielski
Journal:  Am J Pathol       Date:  2010-09       Impact factor: 4.307

2.  Dietary hemoglobin rescues young piglets from severe iron deficiency anemia: Duodenal expression profile of genes involved in heme iron absorption.

Authors:  Robert Staroń; Paweł Lipiński; Małgorzata Lenartowicz; Aleksandra Bednarz; Anna Gajowiak; Ewa Smuda; Wojciech Krzeptowski; Marek Pieszka; Tamara Korolonek; Iqbal Hamza; Dorine W Swinkels; Rachel P L Van Swelm; Rafał R Starzyński
Journal:  PLoS One       Date:  2017-07-13       Impact factor: 3.240

3.  Supplementation with >Your< Iron Syrup Corrects Iron Status in a Mouse Model of Diet-Induced Iron Deficiency.

Authors:  Tatjana Pirman; Ajda Lenardič; Alenka Nemec Svete; Simon Horvat
Journal:  Biology (Basel)       Date:  2021-04-22

4.  Long-term Effect of Split Iron Dextran/Hemoglobin Supplementation on Erythrocyte and Iron Status, Growth Performance, Carcass Parameters, and Meat Quality of Polish Large White and 990 Line Pigs.

Authors:  Mateusz Szudzik; Paweł Lipiński; Aneta Jończy; Rafał Mazgaj; Marek Pieszka; Marian Kamyczek; Ewa Smuda; Rafał R Starzyński
Journal:  Biol Trace Elem Res       Date:  2019-11-08       Impact factor: 3.738

5.  Iron Promotes Intestinal Development in Neonatal Piglets.

Authors:  Yutian Pu; Shuhui Li; Haitao Xiong; Xiaofeng Zhang; Yizhen Wang; Huahua Du
Journal:  Nutrients       Date:  2018-06-05       Impact factor: 5.717

Review 6.  Iron Supplementation in Suckling Piglets: An Ostensibly Easy Therapy of Neonatal Iron Deficiency Anemia.

Authors:  Mateusz Szudzik; Rafał R Starzyński; Aneta Jończy; Rafał Mazgaj; Małgorzata Lenartowicz; Paweł Lipiński
Journal:  Pharmaceuticals (Basel)       Date:  2018-11-22

Review 7.  Water pollution in Bangladesh and its impact on public health.

Authors:  Md Khalid Hasan; Abrar Shahriar; Kudrat Ullah Jim
Journal:  Heliyon       Date:  2019-08-02

Review 8.  Molecular insights into the regulation of iron metabolism during the prenatal and early postnatal periods.

Authors:  Paweł Lipiński; Agnieszka Styś; Rafał R Starzyński
Journal:  Cell Mol Life Sci       Date:  2012-05-13       Impact factor: 9.261

Review 9.  Review on iron and its importance for human health.

Authors:  Nazanin Abbaspour; Richard Hurrell; Roya Kelishadi
Journal:  J Res Med Sci       Date:  2014-02       Impact factor: 1.852

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.